Vimarsana
Biggest News Aggregation in the World

Product Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Product Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Product Candidate Today - Breaking & Trending Today

Decoding Karuna Therapeutics Inc (KRTX): A Strategic SWOT Insight - Vimarsana News

Decoding Karuna Therapeutics Inc (KRTX): A Strategic SWOT Insight

Unveiling the Strengths and Challenges: A Deep Dive into Karuna Therapeutics Inc (KRTX) SWOT Analysis

Source: yahoo.com
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome - Vimarsana News

Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome

Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome Equal Partnership with AFT Pharmaceuticals for Development of a Novel Locally-Acting Product Candidate in Burning Mouth...

Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome - Vimarsana News

Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome

Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth SyndromeEqual Partnership with AFT Pharmaceuticals for Development of a Nove...

Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000 - Vimarsana News

Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000

Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest

Source: yahoo.com
Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine - Vimarsana News

Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine

ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at the annual meeting of the American Society of Reproductive Medicine (ASRM): “The Past, The Present, and The Pipeline”, being held in New Orleans, Lo

Source: yahoo.com